80210-62-4

80210-62-4 structure

Name: cefpodoxime
Chemical Name: cefpodoxime
CAS Number: 80210-62-4
Molecular Formula: C₁₅H₁₇N₅O₆S₂
Molecular Weight: 427.455
Catalog: API Antibiotics Cephalosporin
Create Date: 2018-04-17 08:00:00
Modify Date: 2024-01-03 12:08:51
Cefpodoxime (Cefpodoxime acid) is a potent antibiotic active against gram-positive and gram-negative bacteria. Cefpodoxime inhibits the majority of cells in microbial populations. Cefpodoxime can be used for acute otitis media, sinusitis and tosillopharyngitis research[1][2].

Name	cefpodoxime
Synonyms	(6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-[(methyloxy)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Cefpodoxime Acid 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)-1-oxoethyl]amino]-3-(methoxymethyl)-8-oxo-, (6R,7R)- (6R,7R)-7-{[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid cefpodoxime cefpodoxima U 76253A (6R-(6a,7b(Z)))-7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Cefpodoxime Proxetil EP Impurity A Cefpodoxime Proxetil Impurity 1

Description	Cefpodoxime (Cefpodoxime acid) is a potent antibiotic active against gram-positive and gram-negative bacteria. Cefpodoxime inhibits the majority of cells in microbial populations. Cefpodoxime can be used for acute otitis media, sinusitis and tosillopharyngitis research[1][2].
Related Catalog	Research Areas >> Infection Signaling Pathways >> Anti-infection >> Bacterial
In Vitro	Cefpodoxime (Cefpodoxime acid) inhibits gram-negative anaerobic rods (Bacteroidaceae) with MIC values of 0.125-4 mg/L. Cefpodoxime inhibits Veillonella parvula with MIC values of 0.25-8 mg/L. Cefpodoxime inhibits Peptostreptococcus micros, Peptostreptococcus asaccharolyticus and Ruminococcus bromii with MIC values of <2 mg/L[1]. Cefpodoxime (Cefpodoxime acid) inhibits bacterial populations of S. pneumoniae and S. pyogenes. cfu[2].
In Vivo	Cephalosporins (2.5-50 mg/kg; p.o.; every 8 hours; for 48 hours) have good curative effect in mice[3]. Animal Model: Female Swiss CD1 mice[3] Dosage: 2.5, 5, 10, 25, 40 and 50 mg/kg Administration: Oral administration; every 8 hours; for 48 hours Result: Efficacy was obtained with values of >350.
References	[1]. Werner H, et, al. Comparative in vitro activity of cefpodoxime against anaerobes other than Bacteroides fragilis. Infection. 1991 Sep-Oct;19(5):377-9. [2]. Valentini S, et, al. In-vitro evaluation of cefpodoxime. J Antimicrob Chemother. 1994 Mar;33(3):495-508. [3]. Pérez-Trallero E, et, al. Prediction of in-vivo efficacy by in-vitro early bactericidal activity with oral beta-lactams, in a dose-ranging immunocompetent mouse sepsis model, using strains of Streptococcus pneumoniae with decreasing susceptibilities to penicillin. J Chemother. 2001 Apr;13(2):118-25.

Density	1.8±0.1 g/cm3
Melting Point	200-202ºC
Molecular Formula	C₁₅H₁₇N₅O₆S₂
Molecular Weight	427.455
Exact Mass	427.062012
PSA	209.98000
LogP	0.94
Index of Refraction	1.780

Symbol	GHS08
Signal Word	Danger
Hazard Statements	H317-H334
Precautionary Statements	P261-P280-P342 + P311
Hazard Codes	Xn
Risk Phrases	42/43
Safety Phrases	22-36/37-45
RIDADR	NONH for all modes of transport

80756-85-0

24701-69-7

80210-62-4

Literature: WO2011/77217 A1, ; Page/Page column 9 ;

957-68-6

80210-62-4

Literature: WO2013/41999 A1, ;

82618-98-2

126747-46-4

80210-62-4

126617-55-8

Literature: Chemical and Pharmaceutical Bulletin, , vol. 37, # 9 p. 2369 - 2374

Precursor 4
80756-85-0 24701-69-7 957-68-6 82618-98-2
DownStream 1
87239-81-4

80210-62-4	82619-04-3
105889-80-3	87239-81-4
947692-14-0	217803-89-9
947692-13-9	947692-15-1
339528-86-8	96680-30-7
1158522-08-7	1219572-97-0
940364-43-2	134104-43-1
131615-57-1	6906-52-1
930439-75-1	1018584-77-4
1251579-05-1	1172709-18-0